Four biotechs form advocacy group for antibiotics

Four biotech companies formed the Antibiotics Working Group (AWG) to lobby Congress and FDA on commercial, regulatory and reimbursement policies that could facilitate the development of new antibacterial drugs. The biotechs are Cempra Inc. (NASDAQ:CEMP), Durata Therapeutics Inc. (NASDAQ:DRTX), Optimer Pharmaceuticals Inc. (NASDAQ:OPTR) and Trius Therapeutics Inc. (NASDAQ:TSRX). The AWG is aiming to build on incentives and regulatory policies created by the Generating Antibiotics Incentives Now (GAIN) Act, Trius President and CEO Jeff Stein told BioCentury (see BioCentury, Nov. 19, 2012). ...